title: Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers.
abstract: Hepatitis C virus (HCV) infection is a major public health problem, affecting an estimated 3% of the world's population, and over 10% in some countries. Infection in most cases becomes persistent, and can lead to hepatic inflammation, fibrosis and liver failure. The T lymphocyte reponse, in particular that mediated by cytotoxic T lymphocytes (CTLs), is likely to be involved in determining the outcome of infection, although its overall role is not clear. The use of major histocompatibility complex (MHC) class I peptide tetrameric complexes (tetramers) to study antiviral CTL responses has revolutionized our approach to the study of human infection. We have used a panel of MHC class I tetramers to analyse immune responses in HCV-infected individuals at various stages of disease. We find that the CTL response against HCV is vigorous in its early phases but dwindles over time both in terms of lymphocyte number and function. A number of potential explanations for this 'CTL failure' are discussed.
authors.affiliation: Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, UK.
authors.forename: F
authors.initials: F
authors.lastname: Lechner
authors.forename: J
authors.initials: J
authors.lastname: Sullivan
authors.forename: H
authors.initials: H
authors.lastname: Spiegel
authors.forename: D F
authors.initials: DF
authors.lastname: Nixon
authors.forename: B
authors.initials: B
authors.lastname: Ferrari
authors.forename: A
authors.initials: A
authors.lastname: Davis
authors.forename: B
authors.initials: B
authors.lastname: Borkowsky
authors.forename: H
authors.initials: H
authors.lastname: Pollack
authors.forename: E
authors.initials: E
authors.lastname: Barnes
authors.forename: G
authors.initials: G
authors.lastname: Dusheiko
authors.forename: P
authors.initials: P
authors.lastname: Klenerman
mesh_terms: D000328:Adult; D002648:Child; D005260:Female; D005434:Flow Cytometry; D015658:HIV Infections / Q000150:complications; D016174:Hepacivirus / Q000276:immunology*; D006526:Hepatitis C / Q000150:complications / Q000276:immunology* / Q000821:virology*; D015395:Histocompatibility Antigens Class I / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D008213:Lymphocyte Activation; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology* / Q000378:metabolism
chemical_list: D015395:Histocompatibility Antigens Class I